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Abstract 
 
Objectives:  To assess whether small bowel imaging conducted at the time of diagnosis could 
be used as a predictor of small bowel surgical intervention in a pediatric Crohn’s disease 
patient population. 
Methods:  A retrospective analysis of small bowel imaging within 30 days of diagnosis of 
pediatric Crohn’s disease was conducted.  Patients were divide into two groups based on 
small bowel imaging: those with no or minor abnormalities (71%) and those with more 
extensive or obstructive abnormalities (29%).  Medical records were reviewed for small 
bowel surgical intervention and clinic follow-up visits. 
Results: 232 patients were included in the study group (average age at diagnosis 11.7 years).  
Twenty-seven patients (12%) underwent small bowel surgical intervention.  The relative risk 
for small bowel surgical intervention was 2.91 in the group with more extensive imaging 
abnormalities.  The majority of increased surgical risk occurred in the first year after 
diagnosis, when the normal-minor group had a 2% surgical risk and the more abnormal group 
had a 17% surgical risk.  Both groups had a 2-3% surgical risk per year after the first year. 
Conclusions: Small bowel imaging at the time of diagnosis in pediatric Crohn’s disease can 
help predict the risk of small bowel surgical intervention, and should be recommended for all 
newly diagnosed patients.  Nearly one-third of our cohort underwent small bowel surgical 
intervention through eight years of follow-up.  Surgical complications of Crohn’s disease 
often occur in the small bowel, and counseling families about surgical risk is an integral part 
of pediatric Crohn’s disease management. 
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What is Known/What is New 
 
What is Known: 
 Pediatric patients with Crohn’s disease often require surgical therapy. 
 Radiologic evaluation is frequently used to assess Crohn’s disease activity and 
location. 
 Multiple clinical factors have been associated with increased risk for surgery. 
 
What is New: 
 Significantly abnormal small bowel imaging at diagnosis predicts nearly 3x risk of 
intestinal surgery. 
 Most of this increased risk occurs in the first year after diagnosis. 
 Surgery risk remains 2-3% per year after the first year after diagnosis. 
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Introduction 
  
Over the last decade, advances have occurred in imaging the small bowel in patients 
with inflammatory bowel disease.   In patients with known or suspected Crohn’s disease 
(CD), evaluation of the small bowel may be necessary to assess disease activity and extent, as 
well as complications such as strictures, abscesses, or fistulas.   Recent ESPGHAN (Porto 
criteria) guidelines include radiological evaluation of the small bowel as a mandatory part of 
the diagnostic work-up of a newly diagnosed pediatric IBD patient, except in cases where a 
definitive diagnosis of ulcerative colitis is made(1).  Detection of complications, such as 
irreversible bowel stricture, abscess formation or fistulas, can affect medical or surgical 
management. 
A small bowel follow-through (SBFT) was used for many years as the radiologic test 
of choice for evaluation of the small bowel.  More recently, cross-sectional studies, such as 
computed tomography enterography (CTE) and magnetic resonance enterography (MRE) are 
more commonly used for assessing small bowel Crohn’s disease(2).  The main advantages of 
cross sectional imaging are improved assessment of disease activity and increased sensitivity 
in the detection of extramural complications.  The choice of imaging modality involves 
consideration of diagnostic accuracy, cost, radiation exposure, and availability.  In addition, 
novel diagnostic tests, such as capsule endoscopy(3) and balloon enteroscopy(4, 5), are being 
used selectively by pediatric gastroenterologists to assess the small bowel. 
The purpose of this study was to assess whether SBFT study conducted at the time of 
diagnosis could be used as a predictor of small bowel surgical intervention in a pediatric 
Crohn’s disease patient population.  We chose to use SBFT in this retrospective study to 
amass the largest amount of information and follow-up duration as possible.  We believe these 
results can be extrapolated to cross sectional imaging which is becoming standard in CD. Our 
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hypothesis was that a greater percentage of patients with abnormal small bowel imaging at the 
time of diagnosis would require small bowel surgical intervention over time as compared to 
those with normal small bowel imaging. 
  
Materials and Methods 
  
This study was approved by the Indiana University Institutional Review Board. 
The medical records of pediatric patients with an established diagnosis of Crohn's Disease, 
treated in the Division of Pediatric Gastroenterology/Hepatology/Nutrition at Riley Children’s 
Hospital between 1994 and 2011, were reviewed.  These patients were identified from an IRB 
approved Pediatric Inflammatory Bowel Disease database currently maintained by the 
division.  The clinical data of the patients obtained included gender, age, date of diagnosis, 
date of initial diagnostic endoscopy, most recent pediatric GI clinic visit date, and date and 
type of surgical intervention if performed.   
Patients were included if small bowel follow-through imaging was obtained within 
three months of the date of diagnosis.   We created a modified SBFT scoring system based on 
the grading system of Buchman et al.(6) These radiological studies were graded based on the 
original clinical description of findings in the official report and available radiological images.  
These SBFT studies were graded from 0 to 4 using the following scale:  Grade 0 (normal), 
Grade 1 (minimal nodularity, ulcerations, normal luminal diameter, < 5cm involved), Grade 2 
(more extensive ulcers, minimal luminal narrowing, 5-10 cm involved), Grade 3 (fistula, skip 
areas, extensive ulceration, >10 cm involved but no proximal bowel dilatation) and Grade 4 
(proximal bowel dilatation).  Patients who had SBFT findings which were interpreted as being 
normal or mildly abnormal based on the studies grading system (Grades 0-2), were compared 
to patients with SBFT imaging defined as significantly abnormal (Grades 3-4).  The patients’ 
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medical records were then reviewed to determine if they required surgery related to their 
Crohn’s disease.  The surgical interventions documented included any bowel resections, 
fistula closures, or other small bowel surgeries.      
The statistical analysis was based on survival time, which was determined to be the 
time between the date of diagnosis and date of surgery for the patient, with patients censored 
at the date of last recorded GI clinic visit.  These two groups were compared using Kaplan-
Meier analysis examining surgery free status over time.  A chi-square analysis was conducted 
to determine if the rates of surgical intervention were different between the two groups over 
the length of the study. A value of p < 0.05 was considered to represent the presence of a 
statistically significant difference.   We calculated a cumulative surgical frequency by using a 
Kaplan-Meier survival probability estimate over each time period.  Annual surgical risk was 
determined by dividing the number of patients who underwent surgical intervention by the 
number of patients still being followed at the beginning of that year.  Censored patients were 
removed from the total surgical-free patients at the end of each year, which gives the number 
of patients still being followed for the beginning of the next year.  Compound conditional 
probability was then used to calculate the overall surgical risk at the end of each subsequent 
year.  All values are described as mean + standard deviation, except where noted.    
Results 
 
The medical records of more than 500 pediatric patients with an established diagnosis 
of Crohn's Disease were reviewed.  Two hundred and forty patients were identified to have a 
SBFT performed within three months of the time of their diagnosis of Crohn's Disease.  One 
patient was excluded from the study group because no records of pediatric GI clinic 
visitations were obtained indicating a lack of follow-up.  Four patients were excluded from 
the study group due to difficulty interpreting their SBFT radiological reports due to minimal 
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information reported, vague descriptive terminology used, and lack of quality available 
imaging.  Three patients were excluded from the study group because they had surgical 
intervention prior to their diagnosis which may have been a result of Crohn’s disease.   
The final study group included 232 patients with a mean age at the time of diagnosis 
of 11.7 + 3.5 years.  The study population consisted of 98 females and 134 males.  The 
average time from diagnosis to the time of SBFT was 7 + 17 days. 
Eighty-six patients (37%) were given a Grade 0 (normal) using the SBFT grading 
scale (Figure 1).  Sixty-seven patients (29%) were given a Grade 1, thirty patients (13%) were 
given a Grade 2, thirty-nine patients (17%) were given a Grade 3, and ten patients (4%) were 
given a Grade 4.   
Twenty-seven patients (12%) were identified who underwent small bowel surgical 
intervention for Crohn’s disease during follow-up.  Some patients underwent more than one 
surgical intervention at the time of their first surgery.   Eighteen patients (8%) underwent 
ileocecal resection with primary anastomosis.  Seven patients (3%) underwent small bowel 
resection- six ileal and one jejunal, with primary anastamosis.  Two patients underwent fistula 
closure.  One patient underwent gastrojejunostomy for duodenal stricture.  The surgical 
frequency of the entire cohort of patients was 5% by one year, 16% by 5 years, and 33% by 8 
years after diagnosis (Table 1). 
  Sixteen of the twenty-seven patients who underwent surgery were from Grades 0-2, 
while 11 were from Grades 3-4.  Kaplan-Meier analysis (Figure 2) revealed a significantly 
(p<0.01) different risk of surgical resection between patients with Grades 0-2 and Grades 3-4.  
The relative risk of small bowel surgical intervention was 2.91 with standard error of 1.14 for 
patients with Grades 3-4 compared to patients with Grades 0-2.  
The surgical frequency in patients with Grades 0-2 was 2% by one year, 11% by 5 
years, and 29% by 8 years after diagnosis (Table 1).  The surgical frequency in patients with 
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Grades 3-4 was 17% by one year, 27% by 5 years, and 42% by 8 years after diagnosis. The 
difference in surgical intervention between the two groups was nearly completely explained 
by the different rates of surgical intervention in the first year.  Among all patients, after the 
first year, the frequency of small bowel surgical intervention was 2-3% per year.    
 
Discussion 
 
Our study demonstrates that SBFT imaging conducted at the time of diagnosis in 
pediatric Crohn’s disease helps predict the risk of surgical resection.  The data obtained from 
our study suggest that there is a strong correlation between markedly abnormal small bowel 
imaging at the time of diagnosis and increased future risk of the pediatric patient requiring 
small bowel surgery.  Patients in our study with more extensive SBFT abnormalities at the 
time of diagnosis had a nearly three-fold increased risk for small bowel surgery.  Reliable 
detection and classification of these abnormalities by the pediatric gastroenterologist would 
prove to be invaluable in patient counseling and management. 
Our patients with more abnormal radiologic studies of small bowel at diagnosis of 
Crohn’s disease had an increased risk of surgery in the first year after diagnosis (2% vs. 17%).  
Delay in diagnosis has been correlated with the risk of stenotic disease and intestinal 
surgery.(7)  Following the first year, the rates of surgery were fairly similar between the two 
groups, between 2-3% per year between years 1 and 5 after diagnosis.  This may indicate that 
patients with a fibrostenotic phenotype of Crohn’s disease may have significant stenosis at 
diagnosis which is not amenable to medical therapy, and these patients may benefit from more 
rapid surgical therapy.  As newer therapies become available and widely used in pediatric 
patients, the risk of surgery in patients with more abnormal small bowel imaging may be 
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decreased.  Regardless of the initial radiologic findings, current therapies appear to be limiting 
further stenotic disease and small bowel surgical resection to a low rate. 
Previously published longitudinal studies of Crohn’s disease patients demonstrate that 
pediatric and adult Crohn’s disease patients have increased risk of surgery over time.  Gupta 
et al. demonstrated that pediatric Crohn’s patients had a cumulative incidence of surgery of 
6% at 1 year, 17% at 5 years and 28% at 10 years.  This study also demonstrated that 
development of an abscess, stricture or fistula was associated with an increased risk of 
surgery.(8)  As an overall cohort, the frequency of surgery we observed was remarkably 
similar to that of Gupta et al. Longitudinal studies in the adult Crohn’s population have shown 
a greater cumulative incidence of surgery over time.  Bernell et al.(9) described a cumulative 
rate of intestinal resection of 44%, 62% and 71% at 1, 5 and 10 years following diagnosis.     
Multiple clinical factors have been associated with an increased risk of intestinal 
surgery in Crohn’s disease.(10)  Surgical risk may be increased in the presence of a NOD2 
mutation.(11, 12)  The presence of perianal disease was independently associated with the 
need for surgery.(12)  The presence of ASCA Ig positive serology was also associated with 
stricturing disease and surgery.(13)  Interestingly, mood or anxiety co-morbidity was 
associated with a 28% increased risk for surgery.(14)  In a pediatric cohort, stenotic disease, 
penetrating disease, upper gastrointestinal involvement, and age at diagnosis of less than 14 
years were associated with increased risk of a second surgical resection.(15) In a query of the 
NIDK IBD Genetics Consortium, the presence of any L4 disease phenotype was associated 
with stricturing disease, and L4-jejunal patients were more than twice as likely as L4-EGD 
patients to have had any or multiple surgeries.(16) 
The limitations of our study include its retrospective nature.  Not every patient 
diagnosed with Crohn’s disease at our institution was included.   Some patients did not 
undergo SBFT imaging within the allotted time frame required as part of our study design.  
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Due to physician choice, often patients may not have undergone SBFT imaging at all.  Also, 
SBFT studies are often interpreted real-time and retrospective review of images allowed only 
for our reinterpretation of static images.  Some patients in the study may have been lost to 
follow up due to transition to a different pediatric gastroenterologist or an adult 
gastroenterologist. 
Our study was also limited by the rapidly changing treatments available for Crohn’s 
disease during the time course of this study.  Infliximab was approved by the FDA for 
Crohn’s disease for adults in 1998 and for pediatrics in 2006, adalimumab was approved by 
the FDA for Crohn’s disease for adults in 2007, and certolizumab was approved by the FDA 
for Crohn’s disease in adults in 2008.  Despite these approvals, the risks of surgery noted in 
this study are consistent with prior studies. In addition, the risks of surgery during the first 
year following diagnosis, especially in the cohort of patients with more abnormal small bowel 
imaging studies, may not be amenable to more aggressive therapy, as fibrostenotic changes 
may have occurred prior to diagnosis. 
Although our study used SBFT to define small bowel radiologic abnormalities, MRE 
is rapidly becoming the routine radiological imaging of choice in pediatric Crohn’s disease, 
due to its excellent cross-sectional findings and lack of radiation.  A systematic review of 
MRE for assessment of small bowel activity in pediatric Crohn’s disease gave excellent 
sensitivity and specificity, 84% and 97% respectively, using endoscopy as reference standard, 
although heterogeneity in bowel preparation, scanning technique, and reporting methodology 
was noted(17).  A study of preoperative MRE in patients with Crohn’s disease noted accuracy 
for identification of abscesses but not fistulas or stenoses(18), suggesting the need for careful 
intraoperative search for additional lesions.  Nevertheless, MRE is becoming the imaging 
modality of choice in pediatric patients with Crohn’s disease(19). 
Copyright © ESPGHAN and NASPGHAN. All rights reserved.
In conclusion, current guidelines published by the European Society for Pediatric 
Gastroenterology, Hepatology and Nutrition (ESPGHAN) have radiological evaluation of the 
small bowel as a mandatory part of the evaluation of a patient suspected to have inflammatory 
bowel disease, except in cases where a definite diagnosis of ulcerative colitis is made(1).  At 
this time, the North American Society for Pediatric Gastroenterology, Hepatology and 
Nutrition (NASPHGAN) has no current recommendations for imaging the small bowel in 
newly diagnosed Crohn’s disease patients.  We believe that all newly diagnosed patients with 
Crohn’s disease would benefit from radiological imaging of the small bowel.  This imaging 
may help counsel patients and families about long-term surgical risk and may help guide 
treatment.   
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Figure Legends 
Figure 1:  Distribution of small bowel follow-through scores among the 232 patients included 
in the study. Grade 0 (normal), Grade 1 (minimal nodularity, ulcerations, normal luminal 
diameter, < 5cm involved), Grade 2 (more extensive ulcers, minimal luminal narrowing, 5-10 
cm involved), Grade 3 (fistula, skip areas, extensive ulceration, >10 cm involved but no 
proximal bowel dilatation) and Grade 4 (proximal bowel dilatation). 
 
Figure 2: Kaplan-Meier curve comparing patients in Group 0 (Grades 0-2 small bowel follow-
through) with Group 1 (Grades 3-4 small bowel follow-through).  Proportion surviving 
indicates percentage of patients who remained surgery-free.  Time measured in days from 
diagnosis of Crohn’s disease. 
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Figure 2 
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TABLE 1. Frequency of small bowel surgical intervention in newly diagnosed pediatric Crohn’s disease 
patients. 
Group      n  1 year after diagnosis  5 years after diagnosis  8 years after diagnosis  
All patients    232    5%      16%      33% 
Grade 0‐2 imaging  183    2%      11%      29% 
Grade 3‐4 imaging  49    17%      27%      42% 
 
